Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Reiteration
  • Small Cap
  • Trading Ideas

Mizuho On Atara Biotherapeutics – Distinguish Between Small Numbers And Science Failure

By Vandana Singh
July 13, 1:39 PM
Atara Biotherapeutics Inc (NASDAQ:ATRA) issued its anticipated interim analysis communication for its ATA188 Phase 2 progressive multiple sclerosis trial. Shares slumped…

ATRA

Read More
1 minute read
  • General
  • Health Care
  • News
  • Penny Stocks

Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test

By Vandana Singh
July 13, 1:37 PM
Oncocyte Corporation (NASDAQ:OCX) completed the development and clinical validation of the Laboratory Test for its newly-branded VitaGraft Transplant Monitoring tests for…

OCX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News

Sanofi Offloads 17 Products To Neuraxpharm

By Vandana Singh
July 13, 12:38 PM
Sanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum. 

SNY

Read More
3 minute read
  • Entertainment
  • General
  • News
  • Trading Ideas

Streaming Companies Dominate Emmy Award Nominations: How Apple, Netflix And HBO Max Are Shaking Up TV

By Chris Katje
July 13, 12:32 PM
When the 2022 Primetime Emmy Award Nominations were announced Tuesday, a commonality was the dominance of streaming platforms in many categories. Over the years, the number of nominations by streaming companies has been strong and could show that the future of television belongs to streaming.

AAPL

Read More
1 minute read
  • Biotech
  • General
  • News

HUTCHMED Highlights SAVANNAH Trial Data Of Savolitinib Combo In Lung Cancer Setting

By Vandana Singh
July 13, 12:28 PM
HUTCHMED (China) Limited (NASDAQ:HCM) announced the first presentation of results from the ongoing SAVANNAH Phase 2 trial at the upcoming World…

AZN

Read More
2 minute read
  • Education
  • General
  • Hot
  • News
  • Stock Split
  • Trading Ideas

Alphabet Set For 20-1 Stock Split On Friday: What It Will Mean For Google Investors

By AJ Fabino
July 13, 12:23 PM
Google’s parent company, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) is set to execute its 20-1 stock split on Friday after market close, here’s what it means for investors.

AMZN

Read More
1 minute read
  • General
  • News

Real Good Food Unveils New Breakfast Bowls & Bites

By Shivani Kumaresan
July 13, 12:04 PM
Real Good Food Company Inc (NASDAQ:RGF) has expanded its Breakfast platform with new Breakfast Bowls and Breakfast Bites.  Real Good Foods’…

RGF

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Initiation
  • News
  • Price Target

Raymond James Thinks Bath & Body Works ‘Makes A Lot Of Scents’

By Shivani Kumaresan
July 13, 11:23 AM
Raymond James analyst Olivia Tong initiated coverage on Bath & Body Works Inc (NYSE:BBWI) with a Strong Buy rating and a price target of…

BBWI

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck Makes $290M Bet On Prostate Cancer Candidate

By Vandana Singh
July 13, 10:49 AM
Merck & Co Inc (NASDAQ:MRK) and Orion Corporation announced a global development and commercialization agreement for Orion’s ODM-208 and other drugs targeting cytochrome…

MRK

Read More
1 minute read
  • General
  • Government
  • Politics

Vitalik Buterin Says This Syndrome Is Even Worse Than ‘Trump Derangement Syndrome’

By Shanthi Rexaline
July 13, 10:45 AM
Ethereum (CRYPTO: ETH) co-founder Vitalik Buterin on Tuesday chimed in with his thoughts on U.S. political ideologies in a Twitter thread.

ETH

Posts pagination

Previous 1 … 2,333 2,334 2,335 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service